Celldex Therapeutics, Inc. — Form D

Celldex Therapeutics, Inc. of Hampton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-24. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2014-10-24
• Form: D
• Accession: 0001104659-14-073690
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $2.0M
• Investors: 1
• Date of first sale: 2014-10-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-227106

Issuer

• Name: Celldex Therapeutics, Inc.
• CIK: 000744218
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 53 Frontage Road, Suite 220, Hampton, NJ, 08827
• Phone: 908-200-7500

Officers, directors & promoters (9)

More

• CIK 744218 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search